Skip to main content
University of California San Francisco
UCSF Health
Search UCSF
About UCSF
Give to UCSF
UCSF Alpha Clinic
Search
Main navigation
About Us
Our Team
Steering Committee
Contact Us
Clinical Trials
Research Partners
Training & Education
Research Fellowship
News
Revolutionary Care: An Oakland Story
Upcoming Events
Breadcrumb
Home
PNOC018 A Phase 1 Clinical Trial of Autologous T Cells Expressing a TCR Specific For H3.3K27M With Inhibition of Endogenous TCR (KIND T Cells) In HLA-A*0201-positive Participants With Newly Diagnosed H3.3K27M-positive Diffuse Midline Gliomas
PNOC018 A Phase 1 Clinical Trial of Autologous T Cells Expressing a TCR Specific for H3.3K27M With Inhibition of Endogenous TCR (KIND T Cells) in HLA-A*0201-positive Participants With Newly Diagnosed H3.3K27M-positive Diffuse Midline Gliomas
Disease Name
Diffuse Midline Glioma
Study Status
Recruiting
Date
July 18, 2024